Global At-home Molecular Diagnostic Device Market Growth (Status and Outlook) 2026-2032
The global At-home Molecular Diagnostic Device market size is predicted to grow from US$ 735 million in 2025 to US$ 2925 million in 2032; it is expected to grow at a CAGR of 17.5% from 2026 to 2032.
An At-home Molecular Diagnostic Device refers to a molecular diagnostic hardware platform and its matched disposable test cartridge or reagent system designed for household, self-testing, or near-home use. It typically applies nucleic acid amplification, isothermal amplification, microfluidics, fluorescence detection, chip-based reactions, or digital readout technologies to detect pathogens, genetic markers, or disease-related nucleic acid signals from nasal swabs, saliva, urine, vaginal swabs, blood, or other human samples. These devices emphasize simplified operation, closed sample processing, automated result interpretation, and remote data connectivity, enabling certain molecular tests that traditionally relied on central laboratories to move into homes, pharmacies, primary care settings, and telehealth scenarios. Their core value lies in improving test accessibility, shortening diagnostic waiting time, supporting early screening and treatment, and enabling personalized health management, making them an important product form in the transition of molecular diagnostics from hospital laboratories to consumer-level and distributed healthcare.The average gross profit margin of this product is 42%.
At-home molecular diagnostic devices are entering a critical window driven by the miniaturization of molecular testing technologies, the decentralization of healthcare delivery, and rising consumer awareness of health management. After the pandemic, home testing achieved broad market education, and users, physicians, and regulators became more familiar with home sampling, rapid results, and telehealth connectivity. Compared with traditional antigen or immunoassay-based rapid tests, molecular diagnostic devices offer greater technological potential in sensitivity, early detection, and scenario expansion, extending from respiratory infections to sexually transmitted infections, women?s health, genetic risk, chronic disease management, and medication guidance. For CEOs, marketing leaders, and investors, the value of this industry lies not only in selling a device, but also in building recurring demand and a data loop around hardware platforms, disposable cartridges, digital health accounts, and telehealth services.
The commercialization challenge for at-home molecular diagnostic devices lies in the need to deliver both laboratory-level performance and consumer-level usability. Products must provide stable nucleic acid extraction, amplification, contamination control, and result interpretation, while allowing non-professional users to complete sampling, testing, reading, and result understanding with a low error rate in a home environment. Regulators place high expectations on home-use diagnostics in terms of safety, effectiveness, understandable instructions, misinterpretation risk, and user-behavior validation, requiring companies to invest heavily in clinical validation, human factors engineering, and quality systems. Commercially, companies also face challenges related to device pricing, cartridge cost, channel education, physician prescription linkage, and after-sales support. If test results cannot be smoothly connected to medical consultation, medication access, or follow-up care, user value will be weakened. Therefore, real competition in this field is not about a single testing technology, but about the integrated strength of product reliability, user experience, compliance capability, and healthcare-loop integration.
Downstream demand for at-home molecular diagnostic devices will gradually expand from immediate infectious disease assessment to home health management, telehealth, and distributed testing networks. Respiratory infection testing remains the most intuitive and high-frequency entry scenario for consumers, especially for family self-testing, return-to-work or school decisions, and early treatment guidance. Sexual health and women?s health also have strong potential because they involve privacy-sensitive needs, limited willingness to seek in-person care, and high value from rapid results. In the future, pharmacies, online healthcare platforms, insurance-based health management programs, corporate wellness benefits, and primary care institutions may all become important channels for reaching end users. Customer focus will shift from ?whether testing can be done at home? to ?whether the result is trustworthy, whether it can guide the next medical action, and whether the product has continuous-use value.? Platform-based products and menu expansion capability will determine whether companies can move from one-time testing to long-term user relationships.
LPI (LP Information)' newest research report, the ?At-home Molecular Diagnostic Device Industry Forecast? looks at past sales and reviews total world At-home Molecular Diagnostic Device sales in 2025, providing a comprehensive analysis by region and market sector of projected At-home Molecular Diagnostic Device sales for 2026 through 2032. With At-home Molecular Diagnostic Device sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world At-home Molecular Diagnostic Device industry.
This Insight Report provides a comprehensive analysis of the global At-home Molecular Diagnostic Device landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on At-home Molecular Diagnostic Device portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global At-home Molecular Diagnostic Device market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for At-home Molecular Diagnostic Device and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global At-home Molecular Diagnostic Device.
This report presents a comprehensive overview, market shares, and growth opportunities of At-home Molecular Diagnostic Device market by product type, application, key players and key regions and countries.
Segmentation by Type:
An At-home Molecular Diagnostic Device refers to a molecular diagnostic hardware platform and its matched disposable test cartridge or reagent system designed for household, self-testing, or near-home use. It typically applies nucleic acid amplification, isothermal amplification, microfluidics, fluorescence detection, chip-based reactions, or digital readout technologies to detect pathogens, genetic markers, or disease-related nucleic acid signals from nasal swabs, saliva, urine, vaginal swabs, blood, or other human samples. These devices emphasize simplified operation, closed sample processing, automated result interpretation, and remote data connectivity, enabling certain molecular tests that traditionally relied on central laboratories to move into homes, pharmacies, primary care settings, and telehealth scenarios. Their core value lies in improving test accessibility, shortening diagnostic waiting time, supporting early screening and treatment, and enabling personalized health management, making them an important product form in the transition of molecular diagnostics from hospital laboratories to consumer-level and distributed healthcare.The average gross profit margin of this product is 42%.
At-home molecular diagnostic devices are entering a critical window driven by the miniaturization of molecular testing technologies, the decentralization of healthcare delivery, and rising consumer awareness of health management. After the pandemic, home testing achieved broad market education, and users, physicians, and regulators became more familiar with home sampling, rapid results, and telehealth connectivity. Compared with traditional antigen or immunoassay-based rapid tests, molecular diagnostic devices offer greater technological potential in sensitivity, early detection, and scenario expansion, extending from respiratory infections to sexually transmitted infections, women?s health, genetic risk, chronic disease management, and medication guidance. For CEOs, marketing leaders, and investors, the value of this industry lies not only in selling a device, but also in building recurring demand and a data loop around hardware platforms, disposable cartridges, digital health accounts, and telehealth services.
The commercialization challenge for at-home molecular diagnostic devices lies in the need to deliver both laboratory-level performance and consumer-level usability. Products must provide stable nucleic acid extraction, amplification, contamination control, and result interpretation, while allowing non-professional users to complete sampling, testing, reading, and result understanding with a low error rate in a home environment. Regulators place high expectations on home-use diagnostics in terms of safety, effectiveness, understandable instructions, misinterpretation risk, and user-behavior validation, requiring companies to invest heavily in clinical validation, human factors engineering, and quality systems. Commercially, companies also face challenges related to device pricing, cartridge cost, channel education, physician prescription linkage, and after-sales support. If test results cannot be smoothly connected to medical consultation, medication access, or follow-up care, user value will be weakened. Therefore, real competition in this field is not about a single testing technology, but about the integrated strength of product reliability, user experience, compliance capability, and healthcare-loop integration.
Downstream demand for at-home molecular diagnostic devices will gradually expand from immediate infectious disease assessment to home health management, telehealth, and distributed testing networks. Respiratory infection testing remains the most intuitive and high-frequency entry scenario for consumers, especially for family self-testing, return-to-work or school decisions, and early treatment guidance. Sexual health and women?s health also have strong potential because they involve privacy-sensitive needs, limited willingness to seek in-person care, and high value from rapid results. In the future, pharmacies, online healthcare platforms, insurance-based health management programs, corporate wellness benefits, and primary care institutions may all become important channels for reaching end users. Customer focus will shift from ?whether testing can be done at home? to ?whether the result is trustworthy, whether it can guide the next medical action, and whether the product has continuous-use value.? Platform-based products and menu expansion capability will determine whether companies can move from one-time testing to long-term user relationships.
LPI (LP Information)' newest research report, the ?At-home Molecular Diagnostic Device Industry Forecast? looks at past sales and reviews total world At-home Molecular Diagnostic Device sales in 2025, providing a comprehensive analysis by region and market sector of projected At-home Molecular Diagnostic Device sales for 2026 through 2032. With At-home Molecular Diagnostic Device sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world At-home Molecular Diagnostic Device industry.
This Insight Report provides a comprehensive analysis of the global At-home Molecular Diagnostic Device landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on At-home Molecular Diagnostic Device portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global At-home Molecular Diagnostic Device market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for At-home Molecular Diagnostic Device and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global At-home Molecular Diagnostic Device.
This report presents a comprehensive overview, market shares, and growth opportunities of At-home Molecular Diagnostic Device market by product type, application, key players and key regions and countries.
Segmentation by Type:
- At-Home NAAT Analyzer
- Disposable Molecular Test
- Isothermal Amplification Device
- PCR Microdevice
- Other
- Respiratory Infection Testing
- Sexual Health Testing
- Genetic And Wellness Testing
- Chronic Disease Monitoring
- Consumer Screening
- Other
- OTC Consumer Use
- Prescription Home Use
- Remote Care Use
- Pharmacy Retail Use
- Clinical Trial Decentralized Use
- Other
- Home
- Retail Pharmacy
- Other
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Lucira Health
- Cue Health
- Visby Medical
- Aptitude Medical Systems
- Sherlock Biosciences
- Ellume
- Detect
- Ustar Biotechnologies
- Sansure Biotech
- Daan Gene
- Rendu Biotechnology
- BGI Genomics
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global At-home Molecular Diagnostic Device Market Size (2021-2032)
2.1.2 At-home Molecular Diagnostic Device Market Size CAGR by Region (2021 VS 2025 VS 2032)
2.1.3 World Current & Future Analysis for At-home Molecular Diagnostic Device by Country/Region (2021, 2025 & 2032)
2.2 At-home Molecular Diagnostic Device Segment by Type
2.2.1 At-Home NAAT Analyzer
2.2.2 Disposable Molecular Test
2.2.3 Isothermal Amplification Device
2.2.4 PCR Microdevice
2.2.5 Other
2.2.6 At-home Molecular Diagnostic Device Market Size by Type
2.2.6.1 At-home Molecular Diagnostic Device Market Size CAGR by Type (2021 VS 2025 VS 2032)
2.2.6.2 Global At-home Molecular Diagnostic Device Market Size Market Share by Type (2021-2026)
2.3 At-home Molecular Diagnostic Device Segment by Test Area
2.3.1 Respiratory Infection Testing
2.3.2 Sexual Health Testing
2.3.3 Genetic And Wellness Testing
2.3.4 Chronic Disease Monitoring
2.3.5 Consumer Screening
2.3.6 Other
2.3.7 At-home Molecular Diagnostic Device Market Size by Test Area
2.3.7.1 At-home Molecular Diagnostic Device Market Size CAGR by Test Area (2021 VS 2025 VS 2032)
2.3.7.2 Global At-home Molecular Diagnostic Device Market Size Market Share by Test Area (2021-2026)
2.4 At-home Molecular Diagnostic Device Segment by Use Model
2.4.1 OTC Consumer Use
2.4.2 Prescription Home Use
2.4.3 Remote Care Use
2.4.4 Pharmacy Retail Use
2.4.5 Clinical Trial Decentralized Use
2.4.6 Other
2.4.7 At-home Molecular Diagnostic Device Market Size by Use Model
2.4.7.1 At-home Molecular Diagnostic Device Market Size CAGR by Use Model (2021 VS 2025 VS 2032)
2.4.7.2 Global At-home Molecular Diagnostic Device Market Size Market Share by Use Model (2021-2026)
2.5 At-home Molecular Diagnostic Device Segment by Application
2.5.1 Home
2.5.2 Retail Pharmacy
2.5.3 Other
2.5.4 At-home Molecular Diagnostic Device Market Size by Application
2.5.4.1 At-home Molecular Diagnostic Device Market Size CAGR by Application (2021 VS 2025 VS 2032)
2.5.4.2 Global At-home Molecular Diagnostic Device Market Size Market Share by Application (2021-2026)
3 AT-HOME MOLECULAR DIAGNOSTIC DEVICE MARKET SIZE BY PLAYER
3.1 At-home Molecular Diagnostic Device Market Size Market Share by Player
3.1.1 Global At-home Molecular Diagnostic Device Revenue by Player (2021-2026)
3.1.2 Global At-home Molecular Diagnostic Device Revenue Market Share by Player (2021-2026)
3.2 Global At-home Molecular Diagnostic Device Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 AT-HOME MOLECULAR DIAGNOSTIC DEVICE BY REGION
4.1 At-home Molecular Diagnostic Device Market Size by Region (2021-2026)
4.2 Global At-home Molecular Diagnostic Device Annual Revenue by Country/Region (2021-2026)
4.3 Americas At-home Molecular Diagnostic Device Market Size Growth (2021-2026)
4.4 APAC At-home Molecular Diagnostic Device Market Size Growth (2021-2026)
4.5 Europe At-home Molecular Diagnostic Device Market Size Growth (2021-2026)
4.6 Middle East & Africa At-home Molecular Diagnostic Device Market Size Growth (2021-2026)
5 AMERICAS
5.1 Americas At-home Molecular Diagnostic Device Market Size by Country (2021-2026)
5.2 Americas At-home Molecular Diagnostic Device Market Size by Type (2021-2026)
5.3 Americas At-home Molecular Diagnostic Device Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC At-home Molecular Diagnostic Device Market Size by Region (2021-2026)
6.2 APAC At-home Molecular Diagnostic Device Market Size by Type (2021-2026)
6.3 APAC At-home Molecular Diagnostic Device Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe At-home Molecular Diagnostic Device Market Size by Country (2021-2026)
7.2 Europe At-home Molecular Diagnostic Device Market Size by Type (2021-2026)
7.3 Europe At-home Molecular Diagnostic Device Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa At-home Molecular Diagnostic Device by Region (2021-2026)
8.2 Middle East & Africa At-home Molecular Diagnostic Device Market Size by Type (2021-2026)
8.3 Middle East & Africa At-home Molecular Diagnostic Device Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL AT-HOME MOLECULAR DIAGNOSTIC DEVICE MARKET FORECAST
10.1 Global At-home Molecular Diagnostic Device Forecast by Region (2027-2032)
10.1.1 Global At-home Molecular Diagnostic Device Forecast by Region (2027-2032)
10.1.2 Americas At-home Molecular Diagnostic Device Forecast
10.1.3 APAC At-home Molecular Diagnostic Device Forecast
10.1.4 Europe At-home Molecular Diagnostic Device Forecast
10.1.5 Middle East & Africa At-home Molecular Diagnostic Device Forecast
10.2 Americas At-home Molecular Diagnostic Device Forecast by Country (2027-2032)
10.2.1 United States Market At-home Molecular Diagnostic Device Forecast
10.2.2 Canada Market At-home Molecular Diagnostic Device Forecast
10.2.3 Mexico Market At-home Molecular Diagnostic Device Forecast
10.2.4 Brazil Market At-home Molecular Diagnostic Device Forecast
10.3 APAC At-home Molecular Diagnostic Device Forecast by Region (2027-2032)
10.3.1 China At-home Molecular Diagnostic Device Market Forecast
10.3.2 Japan Market At-home Molecular Diagnostic Device Forecast
10.3.3 Korea Market At-home Molecular Diagnostic Device Forecast
10.3.4 Southeast Asia Market At-home Molecular Diagnostic Device Forecast
10.3.5 India Market At-home Molecular Diagnostic Device Forecast
10.3.6 Australia Market At-home Molecular Diagnostic Device Forecast
10.4 Europe At-home Molecular Diagnostic Device Forecast by Country (2027-2032)
10.4.1 Germany Market At-home Molecular Diagnostic Device Forecast
10.4.2 France Market At-home Molecular Diagnostic Device Forecast
10.4.3 UK Market At-home Molecular Diagnostic Device Forecast
10.4.4 Italy Market At-home Molecular Diagnostic Device Forecast
10.4.5 Russia Market At-home Molecular Diagnostic Device Forecast
10.5 Middle East & Africa At-home Molecular Diagnostic Device Forecast by Region (2027-2032)
10.5.1 Egypt Market At-home Molecular Diagnostic Device Forecast
10.5.2 South Africa Market At-home Molecular Diagnostic Device Forecast
10.5.3 Israel Market At-home Molecular Diagnostic Device Forecast
10.5.4 Turkey Market At-home Molecular Diagnostic Device Forecast
10.6 Global At-home Molecular Diagnostic Device Forecast by Type (2027-2032)
10.7 Global At-home Molecular Diagnostic Device Forecast by Application (2027-2032)
10.7.1 GCC Countries Market At-home Molecular Diagnostic Device Forecast
11 KEY PLAYERS ANALYSIS
11.1 Lucira Health
11.1.1 Lucira Health Company Information
11.1.2 Lucira Health At-home Molecular Diagnostic Device Product Offered
11.1.3 Lucira Health At-home Molecular Diagnostic Device Revenue, Gross Margin and Market Share (2021-2026)
11.1.4 Lucira Health Main Business Overview
11.1.5 Lucira Health Latest Developments
11.2 Cue Health
11.2.1 Cue Health Company Information
11.2.2 Cue Health At-home Molecular Diagnostic Device Product Offered
11.2.3 Cue Health At-home Molecular Diagnostic Device Revenue, Gross Margin and Market Share (2021-2026)
11.2.4 Cue Health Main Business Overview
11.2.5 Cue Health Latest Developments
11.3 Visby Medical
11.3.1 Visby Medical Company Information
11.3.2 Visby Medical At-home Molecular Diagnostic Device Product Offered
11.3.3 Visby Medical At-home Molecular Diagnostic Device Revenue, Gross Margin and Market Share (2021-2026)
11.3.4 Visby Medical Main Business Overview
11.3.5 Visby Medical Latest Developments
11.4 Aptitude Medical Systems
11.4.1 Aptitude Medical Systems Company Information
11.4.2 Aptitude Medical Systems At-home Molecular Diagnostic Device Product Offered
11.4.3 Aptitude Medical Systems At-home Molecular Diagnostic Device Revenue, Gross Margin and Market Share (2021-2026)
11.4.4 Aptitude Medical Systems Main Business Overview
11.4.5 Aptitude Medical Systems Latest Developments
11.5 Sherlock Biosciences
11.5.1 Sherlock Biosciences Company Information
11.5.2 Sherlock Biosciences At-home Molecular Diagnostic Device Product Offered
11.5.3 Sherlock Biosciences At-home Molecular Diagnostic Device Revenue, Gross Margin and Market Share (2021-2026)
11.5.4 Sherlock Biosciences Main Business Overview
11.5.5 Sherlock Biosciences Latest Developments
11.6 Ellume
11.6.1 Ellume Company Information
11.6.2 Ellume At-home Molecular Diagnostic Device Product Offered
11.6.3 Ellume At-home Molecular Diagnostic Device Revenue, Gross Margin and Market Share (2021-2026)
11.6.4 Ellume Main Business Overview
11.6.5 Ellume Latest Developments
11.7 Detect
11.7.1 Detect Company Information
11.7.2 Detect At-home Molecular Diagnostic Device Product Offered
11.7.3 Detect At-home Molecular Diagnostic Device Revenue, Gross Margin and Market Share (2021-2026)
11.7.4 Detect Main Business Overview
11.7.5 Detect Latest Developments
11.8 Ustar Biotechnologies
11.8.1 Ustar Biotechnologies Company Information
11.8.2 Ustar Biotechnologies At-home Molecular Diagnostic Device Product Offered
11.8.3 Ustar Biotechnologies At-home Molecular Diagnostic Device Revenue, Gross Margin and Market Share (2021-2026)
11.8.4 Ustar Biotechnologies Main Business Overview
11.8.5 Ustar Biotechnologies Latest Developments
11.9 Sansure Biotech
11.9.1 Sansure Biotech Company Information
11.9.2 Sansure Biotech At-home Molecular Diagnostic Device Product Offered
11.9.3 Sansure Biotech At-home Molecular Diagnostic Device Revenue, Gross Margin and Market Share (2021-2026)
11.9.4 Sansure Biotech Main Business Overview
11.9.5 Sansure Biotech Latest Developments
11.10 Daan Gene
11.10.1 Daan Gene Company Information
11.10.2 Daan Gene At-home Molecular Diagnostic Device Product Offered
11.10.3 Daan Gene At-home Molecular Diagnostic Device Revenue, Gross Margin and Market Share (2021-2026)
11.10.4 Daan Gene Main Business Overview
11.10.5 Daan Gene Latest Developments
11.11 Rendu Biotechnology
11.11.1 Rendu Biotechnology Company Information
11.11.2 Rendu Biotechnology At-home Molecular Diagnostic Device Product Offered
11.11.3 Rendu Biotechnology At-home Molecular Diagnostic Device Revenue, Gross Margin and Market Share (2021-2026)
11.11.4 Rendu Biotechnology Main Business Overview
11.11.5 Rendu Biotechnology Latest Developments
11.12 BGI Genomics
11.12.1 BGI Genomics Company Information
11.12.2 BGI Genomics At-home Molecular Diagnostic Device Product Offered
11.12.3 BGI Genomics At-home Molecular Diagnostic Device Revenue, Gross Margin and Market Share (2021-2026)
11.12.4 BGI Genomics Main Business Overview
11.12.5 BGI Genomics Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global At-home Molecular Diagnostic Device Market Size (2021-2032)
2.1.2 At-home Molecular Diagnostic Device Market Size CAGR by Region (2021 VS 2025 VS 2032)
2.1.3 World Current & Future Analysis for At-home Molecular Diagnostic Device by Country/Region (2021, 2025 & 2032)
2.2 At-home Molecular Diagnostic Device Segment by Type
2.2.1 At-Home NAAT Analyzer
2.2.2 Disposable Molecular Test
2.2.3 Isothermal Amplification Device
2.2.4 PCR Microdevice
2.2.5 Other
2.2.6 At-home Molecular Diagnostic Device Market Size by Type
2.2.6.1 At-home Molecular Diagnostic Device Market Size CAGR by Type (2021 VS 2025 VS 2032)
2.2.6.2 Global At-home Molecular Diagnostic Device Market Size Market Share by Type (2021-2026)
2.3 At-home Molecular Diagnostic Device Segment by Test Area
2.3.1 Respiratory Infection Testing
2.3.2 Sexual Health Testing
2.3.3 Genetic And Wellness Testing
2.3.4 Chronic Disease Monitoring
2.3.5 Consumer Screening
2.3.6 Other
2.3.7 At-home Molecular Diagnostic Device Market Size by Test Area
2.3.7.1 At-home Molecular Diagnostic Device Market Size CAGR by Test Area (2021 VS 2025 VS 2032)
2.3.7.2 Global At-home Molecular Diagnostic Device Market Size Market Share by Test Area (2021-2026)
2.4 At-home Molecular Diagnostic Device Segment by Use Model
2.4.1 OTC Consumer Use
2.4.2 Prescription Home Use
2.4.3 Remote Care Use
2.4.4 Pharmacy Retail Use
2.4.5 Clinical Trial Decentralized Use
2.4.6 Other
2.4.7 At-home Molecular Diagnostic Device Market Size by Use Model
2.4.7.1 At-home Molecular Diagnostic Device Market Size CAGR by Use Model (2021 VS 2025 VS 2032)
2.4.7.2 Global At-home Molecular Diagnostic Device Market Size Market Share by Use Model (2021-2026)
2.5 At-home Molecular Diagnostic Device Segment by Application
2.5.1 Home
2.5.2 Retail Pharmacy
2.5.3 Other
2.5.4 At-home Molecular Diagnostic Device Market Size by Application
2.5.4.1 At-home Molecular Diagnostic Device Market Size CAGR by Application (2021 VS 2025 VS 2032)
2.5.4.2 Global At-home Molecular Diagnostic Device Market Size Market Share by Application (2021-2026)
3 AT-HOME MOLECULAR DIAGNOSTIC DEVICE MARKET SIZE BY PLAYER
3.1 At-home Molecular Diagnostic Device Market Size Market Share by Player
3.1.1 Global At-home Molecular Diagnostic Device Revenue by Player (2021-2026)
3.1.2 Global At-home Molecular Diagnostic Device Revenue Market Share by Player (2021-2026)
3.2 Global At-home Molecular Diagnostic Device Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 AT-HOME MOLECULAR DIAGNOSTIC DEVICE BY REGION
4.1 At-home Molecular Diagnostic Device Market Size by Region (2021-2026)
4.2 Global At-home Molecular Diagnostic Device Annual Revenue by Country/Region (2021-2026)
4.3 Americas At-home Molecular Diagnostic Device Market Size Growth (2021-2026)
4.4 APAC At-home Molecular Diagnostic Device Market Size Growth (2021-2026)
4.5 Europe At-home Molecular Diagnostic Device Market Size Growth (2021-2026)
4.6 Middle East & Africa At-home Molecular Diagnostic Device Market Size Growth (2021-2026)
5 AMERICAS
5.1 Americas At-home Molecular Diagnostic Device Market Size by Country (2021-2026)
5.2 Americas At-home Molecular Diagnostic Device Market Size by Type (2021-2026)
5.3 Americas At-home Molecular Diagnostic Device Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC At-home Molecular Diagnostic Device Market Size by Region (2021-2026)
6.2 APAC At-home Molecular Diagnostic Device Market Size by Type (2021-2026)
6.3 APAC At-home Molecular Diagnostic Device Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe At-home Molecular Diagnostic Device Market Size by Country (2021-2026)
7.2 Europe At-home Molecular Diagnostic Device Market Size by Type (2021-2026)
7.3 Europe At-home Molecular Diagnostic Device Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa At-home Molecular Diagnostic Device by Region (2021-2026)
8.2 Middle East & Africa At-home Molecular Diagnostic Device Market Size by Type (2021-2026)
8.3 Middle East & Africa At-home Molecular Diagnostic Device Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL AT-HOME MOLECULAR DIAGNOSTIC DEVICE MARKET FORECAST
10.1 Global At-home Molecular Diagnostic Device Forecast by Region (2027-2032)
10.1.1 Global At-home Molecular Diagnostic Device Forecast by Region (2027-2032)
10.1.2 Americas At-home Molecular Diagnostic Device Forecast
10.1.3 APAC At-home Molecular Diagnostic Device Forecast
10.1.4 Europe At-home Molecular Diagnostic Device Forecast
10.1.5 Middle East & Africa At-home Molecular Diagnostic Device Forecast
10.2 Americas At-home Molecular Diagnostic Device Forecast by Country (2027-2032)
10.2.1 United States Market At-home Molecular Diagnostic Device Forecast
10.2.2 Canada Market At-home Molecular Diagnostic Device Forecast
10.2.3 Mexico Market At-home Molecular Diagnostic Device Forecast
10.2.4 Brazil Market At-home Molecular Diagnostic Device Forecast
10.3 APAC At-home Molecular Diagnostic Device Forecast by Region (2027-2032)
10.3.1 China At-home Molecular Diagnostic Device Market Forecast
10.3.2 Japan Market At-home Molecular Diagnostic Device Forecast
10.3.3 Korea Market At-home Molecular Diagnostic Device Forecast
10.3.4 Southeast Asia Market At-home Molecular Diagnostic Device Forecast
10.3.5 India Market At-home Molecular Diagnostic Device Forecast
10.3.6 Australia Market At-home Molecular Diagnostic Device Forecast
10.4 Europe At-home Molecular Diagnostic Device Forecast by Country (2027-2032)
10.4.1 Germany Market At-home Molecular Diagnostic Device Forecast
10.4.2 France Market At-home Molecular Diagnostic Device Forecast
10.4.3 UK Market At-home Molecular Diagnostic Device Forecast
10.4.4 Italy Market At-home Molecular Diagnostic Device Forecast
10.4.5 Russia Market At-home Molecular Diagnostic Device Forecast
10.5 Middle East & Africa At-home Molecular Diagnostic Device Forecast by Region (2027-2032)
10.5.1 Egypt Market At-home Molecular Diagnostic Device Forecast
10.5.2 South Africa Market At-home Molecular Diagnostic Device Forecast
10.5.3 Israel Market At-home Molecular Diagnostic Device Forecast
10.5.4 Turkey Market At-home Molecular Diagnostic Device Forecast
10.6 Global At-home Molecular Diagnostic Device Forecast by Type (2027-2032)
10.7 Global At-home Molecular Diagnostic Device Forecast by Application (2027-2032)
10.7.1 GCC Countries Market At-home Molecular Diagnostic Device Forecast
11 KEY PLAYERS ANALYSIS
11.1 Lucira Health
11.1.1 Lucira Health Company Information
11.1.2 Lucira Health At-home Molecular Diagnostic Device Product Offered
11.1.3 Lucira Health At-home Molecular Diagnostic Device Revenue, Gross Margin and Market Share (2021-2026)
11.1.4 Lucira Health Main Business Overview
11.1.5 Lucira Health Latest Developments
11.2 Cue Health
11.2.1 Cue Health Company Information
11.2.2 Cue Health At-home Molecular Diagnostic Device Product Offered
11.2.3 Cue Health At-home Molecular Diagnostic Device Revenue, Gross Margin and Market Share (2021-2026)
11.2.4 Cue Health Main Business Overview
11.2.5 Cue Health Latest Developments
11.3 Visby Medical
11.3.1 Visby Medical Company Information
11.3.2 Visby Medical At-home Molecular Diagnostic Device Product Offered
11.3.3 Visby Medical At-home Molecular Diagnostic Device Revenue, Gross Margin and Market Share (2021-2026)
11.3.4 Visby Medical Main Business Overview
11.3.5 Visby Medical Latest Developments
11.4 Aptitude Medical Systems
11.4.1 Aptitude Medical Systems Company Information
11.4.2 Aptitude Medical Systems At-home Molecular Diagnostic Device Product Offered
11.4.3 Aptitude Medical Systems At-home Molecular Diagnostic Device Revenue, Gross Margin and Market Share (2021-2026)
11.4.4 Aptitude Medical Systems Main Business Overview
11.4.5 Aptitude Medical Systems Latest Developments
11.5 Sherlock Biosciences
11.5.1 Sherlock Biosciences Company Information
11.5.2 Sherlock Biosciences At-home Molecular Diagnostic Device Product Offered
11.5.3 Sherlock Biosciences At-home Molecular Diagnostic Device Revenue, Gross Margin and Market Share (2021-2026)
11.5.4 Sherlock Biosciences Main Business Overview
11.5.5 Sherlock Biosciences Latest Developments
11.6 Ellume
11.6.1 Ellume Company Information
11.6.2 Ellume At-home Molecular Diagnostic Device Product Offered
11.6.3 Ellume At-home Molecular Diagnostic Device Revenue, Gross Margin and Market Share (2021-2026)
11.6.4 Ellume Main Business Overview
11.6.5 Ellume Latest Developments
11.7 Detect
11.7.1 Detect Company Information
11.7.2 Detect At-home Molecular Diagnostic Device Product Offered
11.7.3 Detect At-home Molecular Diagnostic Device Revenue, Gross Margin and Market Share (2021-2026)
11.7.4 Detect Main Business Overview
11.7.5 Detect Latest Developments
11.8 Ustar Biotechnologies
11.8.1 Ustar Biotechnologies Company Information
11.8.2 Ustar Biotechnologies At-home Molecular Diagnostic Device Product Offered
11.8.3 Ustar Biotechnologies At-home Molecular Diagnostic Device Revenue, Gross Margin and Market Share (2021-2026)
11.8.4 Ustar Biotechnologies Main Business Overview
11.8.5 Ustar Biotechnologies Latest Developments
11.9 Sansure Biotech
11.9.1 Sansure Biotech Company Information
11.9.2 Sansure Biotech At-home Molecular Diagnostic Device Product Offered
11.9.3 Sansure Biotech At-home Molecular Diagnostic Device Revenue, Gross Margin and Market Share (2021-2026)
11.9.4 Sansure Biotech Main Business Overview
11.9.5 Sansure Biotech Latest Developments
11.10 Daan Gene
11.10.1 Daan Gene Company Information
11.10.2 Daan Gene At-home Molecular Diagnostic Device Product Offered
11.10.3 Daan Gene At-home Molecular Diagnostic Device Revenue, Gross Margin and Market Share (2021-2026)
11.10.4 Daan Gene Main Business Overview
11.10.5 Daan Gene Latest Developments
11.11 Rendu Biotechnology
11.11.1 Rendu Biotechnology Company Information
11.11.2 Rendu Biotechnology At-home Molecular Diagnostic Device Product Offered
11.11.3 Rendu Biotechnology At-home Molecular Diagnostic Device Revenue, Gross Margin and Market Share (2021-2026)
11.11.4 Rendu Biotechnology Main Business Overview
11.11.5 Rendu Biotechnology Latest Developments
11.12 BGI Genomics
11.12.1 BGI Genomics Company Information
11.12.2 BGI Genomics At-home Molecular Diagnostic Device Product Offered
11.12.3 BGI Genomics At-home Molecular Diagnostic Device Revenue, Gross Margin and Market Share (2021-2026)
11.12.4 BGI Genomics Main Business Overview
11.12.5 BGI Genomics Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. At-home Molecular Diagnostic Device Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. At-home Molecular Diagnostic Device Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of At-Home NAAT Analyzer
Table 4. Major Players of Disposable Molecular Test
Table 5. Major Players of Isothermal Amplification Device
Table 6. Major Players of PCR Microdevice
Table 7. Major Players of Other
Table 8. At-home Molecular Diagnostic Device Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 9. Global At-home Molecular Diagnostic Device Market Size by Type (2021-2026) & ($ millions)
Table 10. Global At-home Molecular Diagnostic Device Market Size Market Share by Type (2021-2026)
Table 11. Major Players of Respiratory Infection Testing
Table 12. Major Players of Sexual Health Testing
Table 13. Major Players of Genetic And Wellness Testing
Table 14. Major Players of Chronic Disease Monitoring
Table 15. Major Players of Consumer Screening
Table 16. Major Players of Other
Table 17. At-home Molecular Diagnostic Device Market Size CAGR by Test Area (2021 VS 2025 VS 2032) & ($ millions)
Table 18. Global At-home Molecular Diagnostic Device Market Size by Test Area (2021-2026) & ($ millions)
Table 19. Global At-home Molecular Diagnostic Device Market Size Market Share by Test Area (2021-2026)
Table 20. Major Players of OTC Consumer Use
Table 21. Major Players of Prescription Home Use
Table 22. Major Players of Remote Care Use
Table 23. Major Players of Pharmacy Retail Use
Table 24. Major Players of Clinical Trial Decentralized Use
Table 25. Major Players of Other
Table 26. At-home Molecular Diagnostic Device Market Size CAGR by Use Model (2021 VS 2025 VS 2032) & ($ millions)
Table 27. Global At-home Molecular Diagnostic Device Market Size by Use Model (2021-2026) & ($ millions)
Table 28. Global At-home Molecular Diagnostic Device Market Size Market Share by Use Model (2021-2026)
Table 29. At-home Molecular Diagnostic Device Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 30. Global At-home Molecular Diagnostic Device Market Size by Application (2021-2026) & ($ millions)
Table 31. Global At-home Molecular Diagnostic Device Market Size Market Share by Application (2021-2026)
Table 32. Global At-home Molecular Diagnostic Device Revenue by Player (2021-2026) & ($ millions)
Table 33. Global At-home Molecular Diagnostic Device Revenue Market Share by Player (2021-2026)
Table 34. At-home Molecular Diagnostic Device Key Players Head office and Products Offered
Table 35. At-home Molecular Diagnostic Device Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 36. New Products and Potential Entrants
Table 37. Mergers & Acquisitions, Expansion
Table 38. Global At-home Molecular Diagnostic Device Market Size by Region (2021-2026) & ($ millions)
Table 39. Global At-home Molecular Diagnostic Device Market Size Market Share by Region (2021-2026)
Table 40. Global At-home Molecular Diagnostic Device Revenue by Country/Region (2021-2026) & ($ millions)
Table 41. Global At-home Molecular Diagnostic Device Revenue Market Share by Country/Region (2021-2026)
Table 42. Americas At-home Molecular Diagnostic Device Market Size by Country (2021-2026) & ($ millions)
Table 43. Americas At-home Molecular Diagnostic Device Market Size Market Share by Country (2021-2026)
Table 44. Americas At-home Molecular Diagnostic Device Market Size by Type (2021-2026) & ($ millions)
Table 45. Americas At-home Molecular Diagnostic Device Market Size Market Share by Type (2021-2026)
Table 46. Americas At-home Molecular Diagnostic Device Market Size by Application (2021-2026) & ($ millions)
Table 47. Americas At-home Molecular Diagnostic Device Market Size Market Share by Application (2021-2026)
Table 48. APAC At-home Molecular Diagnostic Device Market Size by Region (2021-2026) & ($ millions)
Table 49. APAC At-home Molecular Diagnostic Device Market Size Market Share by Region (2021-2026)
Table 50. APAC At-home Molecular Diagnostic Device Market Size by Type (2021-2026) & ($ millions)
Table 51. APAC At-home Molecular Diagnostic Device Market Size by Application (2021-2026) & ($ millions)
Table 52. Europe At-home Molecular Diagnostic Device Market Size by Country (2021-2026) & ($ millions)
Table 53. Europe At-home Molecular Diagnostic Device Market Size Market Share by Country (2021-2026)
Table 54. Europe At-home Molecular Diagnostic Device Market Size by Type (2021-2026) & ($ millions)
Table 55. Europe At-home Molecular Diagnostic Device Market Size by Application (2021-2026) & ($ millions)
Table 56. Middle East & Africa At-home Molecular Diagnostic Device Market Size by Region (2021-2026) & ($ millions)
Table 57. Middle East & Africa At-home Molecular Diagnostic Device Market Size by Type (2021-2026) & ($ millions)
Table 58. Middle East & Africa At-home Molecular Diagnostic Device Market Size by Application (2021-2026) & ($ millions)
Table 59. Key Market Drivers & Growth Opportunities of At-home Molecular Diagnostic Device
Table 60. Key Market Challenges & Risks of At-home Molecular Diagnostic Device
Table 61. Key Industry Trends of At-home Molecular Diagnostic Device
Table 62. Global At-home Molecular Diagnostic Device Market Size Forecast by Region (2027-2032) & ($ millions)
Table 63. Global At-home Molecular Diagnostic Device Market Size Market Share Forecast by Region (2027-2032)
Table 64. Global At-home Molecular Diagnostic Device Market Size Forecast by Type (2027-2032) & ($ millions)
Table 65. Global At-home Molecular Diagnostic Device Market Size Forecast by Application (2027-2032) & ($ millions)
Table 66. Lucira Health Details, Company Type, At-home Molecular Diagnostic Device Area Served and Its Competitors
Table 67. Lucira Health At-home Molecular Diagnostic Device Product Offered
Table 68. Lucira Health At-home Molecular Diagnostic Device Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 69. Lucira Health Main Business
Table 70. Lucira Health Latest Developments
Table 71. Cue Health Details, Company Type, At-home Molecular Diagnostic Device Area Served and Its Competitors
Table 72. Cue Health At-home Molecular Diagnostic Device Product Offered
Table 73. Cue Health At-home Molecular Diagnostic Device Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 74. Cue Health Main Business
Table 75. Cue Health Latest Developments
Table 76. Visby Medical Details, Company Type, At-home Molecular Diagnostic Device Area Served and Its Competitors
Table 77. Visby Medical At-home Molecular Diagnostic Device Product Offered
Table 78. Visby Medical At-home Molecular Diagnostic Device Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 79. Visby Medical Main Business
Table 80. Visby Medical Latest Developments
Table 81. Aptitude Medical Systems Details, Company Type, At-home Molecular Diagnostic Device Area Served and Its Competitors
Table 82. Aptitude Medical Systems At-home Molecular Diagnostic Device Product Offered
Table 83. Aptitude Medical Systems At-home Molecular Diagnostic Device Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 84. Aptitude Medical Systems Main Business
Table 85. Aptitude Medical Systems Latest Developments
Table 86. Sherlock Biosciences Details, Company Type, At-home Molecular Diagnostic Device Area Served and Its Competitors
Table 87. Sherlock Biosciences At-home Molecular Diagnostic Device Product Offered
Table 88. Sherlock Biosciences At-home Molecular Diagnostic Device Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 89. Sherlock Biosciences Main Business
Table 90. Sherlock Biosciences Latest Developments
Table 91. Ellume Details, Company Type, At-home Molecular Diagnostic Device Area Served and Its Competitors
Table 92. Ellume At-home Molecular Diagnostic Device Product Offered
Table 93. Ellume At-home Molecular Diagnostic Device Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 94. Ellume Main Business
Table 95. Ellume Latest Developments
Table 96. Detect Details, Company Type, At-home Molecular Diagnostic Device Area Served and Its Competitors
Table 97. Detect At-home Molecular Diagnostic Device Product Offered
Table 98. Detect At-home Molecular Diagnostic Device Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 99. Detect Main Business
Table 100. Detect Latest Developments
Table 101. Ustar Biotechnologies Details, Company Type, At-home Molecular Diagnostic Device Area Served and Its Competitors
Table 102. Ustar Biotechnologies At-home Molecular Diagnostic Device Product Offered
Table 103. Ustar Biotechnologies At-home Molecular Diagnostic Device Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 104. Ustar Biotechnologies Main Business
Table 105. Ustar Biotechnologies Latest Developments
Table 106. Sansure Biotech Details, Company Type, At-home Molecular Diagnostic Device Area Served and Its Competitors
Table 107. Sansure Biotech At-home Molecular Diagnostic Device Product Offered
Table 108. Sansure Biotech At-home Molecular Diagnostic Device Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 109. Sansure Biotech Main Business
Table 110. Sansure Biotech Latest Developments
Table 111. Daan Gene Details, Company Type, At-home Molecular Diagnostic Device Area Served and Its Competitors
Table 112. Daan Gene At-home Molecular Diagnostic Device Product Offered
Table 113. Daan Gene At-home Molecular Diagnostic Device Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 114. Daan Gene Main Business
Table 115. Daan Gene Latest Developments
Table 116. Rendu Biotechnology Details, Company Type, At-home Molecular Diagnostic Device Area Served and Its Competitors
Table 117. Rendu Biotechnology At-home Molecular Diagnostic Device Product Offered
Table 118. Rendu Biotechnology At-home Molecular Diagnostic Device Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 119. Rendu Biotechnology Main Business
Table 120. Rendu Biotechnology Latest Developments
Table 121. BGI Genomics Details, Company Type, At-home Molecular Diagnostic Device Area Served and Its Competitors
Table 122. BGI Genomics At-home Molecular Diagnostic Device Product Offered
Table 123. BGI Genomics At-home Molecular Diagnostic Device Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 124. BGI Genomics Main Business
Table 125. BGI Genomics Latest Developments
Table 1. At-home Molecular Diagnostic Device Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. At-home Molecular Diagnostic Device Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of At-Home NAAT Analyzer
Table 4. Major Players of Disposable Molecular Test
Table 5. Major Players of Isothermal Amplification Device
Table 6. Major Players of PCR Microdevice
Table 7. Major Players of Other
Table 8. At-home Molecular Diagnostic Device Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 9. Global At-home Molecular Diagnostic Device Market Size by Type (2021-2026) & ($ millions)
Table 10. Global At-home Molecular Diagnostic Device Market Size Market Share by Type (2021-2026)
Table 11. Major Players of Respiratory Infection Testing
Table 12. Major Players of Sexual Health Testing
Table 13. Major Players of Genetic And Wellness Testing
Table 14. Major Players of Chronic Disease Monitoring
Table 15. Major Players of Consumer Screening
Table 16. Major Players of Other
Table 17. At-home Molecular Diagnostic Device Market Size CAGR by Test Area (2021 VS 2025 VS 2032) & ($ millions)
Table 18. Global At-home Molecular Diagnostic Device Market Size by Test Area (2021-2026) & ($ millions)
Table 19. Global At-home Molecular Diagnostic Device Market Size Market Share by Test Area (2021-2026)
Table 20. Major Players of OTC Consumer Use
Table 21. Major Players of Prescription Home Use
Table 22. Major Players of Remote Care Use
Table 23. Major Players of Pharmacy Retail Use
Table 24. Major Players of Clinical Trial Decentralized Use
Table 25. Major Players of Other
Table 26. At-home Molecular Diagnostic Device Market Size CAGR by Use Model (2021 VS 2025 VS 2032) & ($ millions)
Table 27. Global At-home Molecular Diagnostic Device Market Size by Use Model (2021-2026) & ($ millions)
Table 28. Global At-home Molecular Diagnostic Device Market Size Market Share by Use Model (2021-2026)
Table 29. At-home Molecular Diagnostic Device Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 30. Global At-home Molecular Diagnostic Device Market Size by Application (2021-2026) & ($ millions)
Table 31. Global At-home Molecular Diagnostic Device Market Size Market Share by Application (2021-2026)
Table 32. Global At-home Molecular Diagnostic Device Revenue by Player (2021-2026) & ($ millions)
Table 33. Global At-home Molecular Diagnostic Device Revenue Market Share by Player (2021-2026)
Table 34. At-home Molecular Diagnostic Device Key Players Head office and Products Offered
Table 35. At-home Molecular Diagnostic Device Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 36. New Products and Potential Entrants
Table 37. Mergers & Acquisitions, Expansion
Table 38. Global At-home Molecular Diagnostic Device Market Size by Region (2021-2026) & ($ millions)
Table 39. Global At-home Molecular Diagnostic Device Market Size Market Share by Region (2021-2026)
Table 40. Global At-home Molecular Diagnostic Device Revenue by Country/Region (2021-2026) & ($ millions)
Table 41. Global At-home Molecular Diagnostic Device Revenue Market Share by Country/Region (2021-2026)
Table 42. Americas At-home Molecular Diagnostic Device Market Size by Country (2021-2026) & ($ millions)
Table 43. Americas At-home Molecular Diagnostic Device Market Size Market Share by Country (2021-2026)
Table 44. Americas At-home Molecular Diagnostic Device Market Size by Type (2021-2026) & ($ millions)
Table 45. Americas At-home Molecular Diagnostic Device Market Size Market Share by Type (2021-2026)
Table 46. Americas At-home Molecular Diagnostic Device Market Size by Application (2021-2026) & ($ millions)
Table 47. Americas At-home Molecular Diagnostic Device Market Size Market Share by Application (2021-2026)
Table 48. APAC At-home Molecular Diagnostic Device Market Size by Region (2021-2026) & ($ millions)
Table 49. APAC At-home Molecular Diagnostic Device Market Size Market Share by Region (2021-2026)
Table 50. APAC At-home Molecular Diagnostic Device Market Size by Type (2021-2026) & ($ millions)
Table 51. APAC At-home Molecular Diagnostic Device Market Size by Application (2021-2026) & ($ millions)
Table 52. Europe At-home Molecular Diagnostic Device Market Size by Country (2021-2026) & ($ millions)
Table 53. Europe At-home Molecular Diagnostic Device Market Size Market Share by Country (2021-2026)
Table 54. Europe At-home Molecular Diagnostic Device Market Size by Type (2021-2026) & ($ millions)
Table 55. Europe At-home Molecular Diagnostic Device Market Size by Application (2021-2026) & ($ millions)
Table 56. Middle East & Africa At-home Molecular Diagnostic Device Market Size by Region (2021-2026) & ($ millions)
Table 57. Middle East & Africa At-home Molecular Diagnostic Device Market Size by Type (2021-2026) & ($ millions)
Table 58. Middle East & Africa At-home Molecular Diagnostic Device Market Size by Application (2021-2026) & ($ millions)
Table 59. Key Market Drivers & Growth Opportunities of At-home Molecular Diagnostic Device
Table 60. Key Market Challenges & Risks of At-home Molecular Diagnostic Device
Table 61. Key Industry Trends of At-home Molecular Diagnostic Device
Table 62. Global At-home Molecular Diagnostic Device Market Size Forecast by Region (2027-2032) & ($ millions)
Table 63. Global At-home Molecular Diagnostic Device Market Size Market Share Forecast by Region (2027-2032)
Table 64. Global At-home Molecular Diagnostic Device Market Size Forecast by Type (2027-2032) & ($ millions)
Table 65. Global At-home Molecular Diagnostic Device Market Size Forecast by Application (2027-2032) & ($ millions)
Table 66. Lucira Health Details, Company Type, At-home Molecular Diagnostic Device Area Served and Its Competitors
Table 67. Lucira Health At-home Molecular Diagnostic Device Product Offered
Table 68. Lucira Health At-home Molecular Diagnostic Device Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 69. Lucira Health Main Business
Table 70. Lucira Health Latest Developments
Table 71. Cue Health Details, Company Type, At-home Molecular Diagnostic Device Area Served and Its Competitors
Table 72. Cue Health At-home Molecular Diagnostic Device Product Offered
Table 73. Cue Health At-home Molecular Diagnostic Device Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 74. Cue Health Main Business
Table 75. Cue Health Latest Developments
Table 76. Visby Medical Details, Company Type, At-home Molecular Diagnostic Device Area Served and Its Competitors
Table 77. Visby Medical At-home Molecular Diagnostic Device Product Offered
Table 78. Visby Medical At-home Molecular Diagnostic Device Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 79. Visby Medical Main Business
Table 80. Visby Medical Latest Developments
Table 81. Aptitude Medical Systems Details, Company Type, At-home Molecular Diagnostic Device Area Served and Its Competitors
Table 82. Aptitude Medical Systems At-home Molecular Diagnostic Device Product Offered
Table 83. Aptitude Medical Systems At-home Molecular Diagnostic Device Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 84. Aptitude Medical Systems Main Business
Table 85. Aptitude Medical Systems Latest Developments
Table 86. Sherlock Biosciences Details, Company Type, At-home Molecular Diagnostic Device Area Served and Its Competitors
Table 87. Sherlock Biosciences At-home Molecular Diagnostic Device Product Offered
Table 88. Sherlock Biosciences At-home Molecular Diagnostic Device Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 89. Sherlock Biosciences Main Business
Table 90. Sherlock Biosciences Latest Developments
Table 91. Ellume Details, Company Type, At-home Molecular Diagnostic Device Area Served and Its Competitors
Table 92. Ellume At-home Molecular Diagnostic Device Product Offered
Table 93. Ellume At-home Molecular Diagnostic Device Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 94. Ellume Main Business
Table 95. Ellume Latest Developments
Table 96. Detect Details, Company Type, At-home Molecular Diagnostic Device Area Served and Its Competitors
Table 97. Detect At-home Molecular Diagnostic Device Product Offered
Table 98. Detect At-home Molecular Diagnostic Device Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 99. Detect Main Business
Table 100. Detect Latest Developments
Table 101. Ustar Biotechnologies Details, Company Type, At-home Molecular Diagnostic Device Area Served and Its Competitors
Table 102. Ustar Biotechnologies At-home Molecular Diagnostic Device Product Offered
Table 103. Ustar Biotechnologies At-home Molecular Diagnostic Device Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 104. Ustar Biotechnologies Main Business
Table 105. Ustar Biotechnologies Latest Developments
Table 106. Sansure Biotech Details, Company Type, At-home Molecular Diagnostic Device Area Served and Its Competitors
Table 107. Sansure Biotech At-home Molecular Diagnostic Device Product Offered
Table 108. Sansure Biotech At-home Molecular Diagnostic Device Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 109. Sansure Biotech Main Business
Table 110. Sansure Biotech Latest Developments
Table 111. Daan Gene Details, Company Type, At-home Molecular Diagnostic Device Area Served and Its Competitors
Table 112. Daan Gene At-home Molecular Diagnostic Device Product Offered
Table 113. Daan Gene At-home Molecular Diagnostic Device Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 114. Daan Gene Main Business
Table 115. Daan Gene Latest Developments
Table 116. Rendu Biotechnology Details, Company Type, At-home Molecular Diagnostic Device Area Served and Its Competitors
Table 117. Rendu Biotechnology At-home Molecular Diagnostic Device Product Offered
Table 118. Rendu Biotechnology At-home Molecular Diagnostic Device Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 119. Rendu Biotechnology Main Business
Table 120. Rendu Biotechnology Latest Developments
Table 121. BGI Genomics Details, Company Type, At-home Molecular Diagnostic Device Area Served and Its Competitors
Table 122. BGI Genomics At-home Molecular Diagnostic Device Product Offered
Table 123. BGI Genomics At-home Molecular Diagnostic Device Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 124. BGI Genomics Main Business
Table 125. BGI Genomics Latest Developments
LIST OF FIGURES
Figure 1. At-home Molecular Diagnostic Device Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global At-home Molecular Diagnostic Device Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. At-home Molecular Diagnostic Device Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. At-home Molecular Diagnostic Device Sales Market Share by Country/Region (2025)
Figure 8. At-home Molecular Diagnostic Device Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global At-home Molecular Diagnostic Device Market Size Market Share by Type in 2025
Figure 10. Global At-home Molecular Diagnostic Device Market Size Market Share by Test Area in 2025
Figure 11. Global At-home Molecular Diagnostic Device Market Size Market Share by Use Model in 2025
Figure 12. At-home Molecular Diagnostic Device in Home
Figure 13. Global At-home Molecular Diagnostic Device Market: Home (2021-2026) & ($ millions)
Figure 14. At-home Molecular Diagnostic Device in Retail Pharmacy
Figure 15. Global At-home Molecular Diagnostic Device Market: Retail Pharmacy (2021-2026) & ($ millions)
Figure 16. At-home Molecular Diagnostic Device in Other
Figure 17. Global At-home Molecular Diagnostic Device Market: Other (2021-2026) & ($ millions)
Figure 18. Global At-home Molecular Diagnostic Device Market Size Market Share by Application in 2025
Figure 19. Global At-home Molecular Diagnostic Device Revenue Market Share by Player in 2025
Figure 20. Global At-home Molecular Diagnostic Device Market Size Market Share by Region (2021-2026)
Figure 21. Americas At-home Molecular Diagnostic Device Market Size 2021-2026 ($ millions)
Figure 22. APAC At-home Molecular Diagnostic Device Market Size 2021-2026 ($ millions)
Figure 23. Europe At-home Molecular Diagnostic Device Market Size 2021-2026 ($ millions)
Figure 24. Middle East & Africa At-home Molecular Diagnostic Device Market Size 2021-2026 ($ millions)
Figure 25. Americas At-home Molecular Diagnostic Device Value Market Share by Country in 2025
Figure 26. United States At-home Molecular Diagnostic Device Market Size Growth 2021-2026 ($ millions)
Figure 27. Canada At-home Molecular Diagnostic Device Market Size Growth 2021-2026 ($ millions)
Figure 28. Mexico At-home Molecular Diagnostic Device Market Size Growth 2021-2026 ($ millions)
Figure 29. Brazil At-home Molecular Diagnostic Device Market Size Growth 2021-2026 ($ millions)
Figure 30. APAC At-home Molecular Diagnostic Device Market Size Market Share by Region in 2025
Figure 31. APAC At-home Molecular Diagnostic Device Market Size Market Share by Type (2021-2026)
Figure 32. APAC At-home Molecular Diagnostic Device Market Size Market Share by Application (2021-2026)
Figure 33. China At-home Molecular Diagnostic Device Market Size Growth 2021-2026 ($ millions)
Figure 34. Japan At-home Molecular Diagnostic Device Market Size Growth 2021-2026 ($ millions)
Figure 35. South Korea At-home Molecular Diagnostic Device Market Size Growth 2021-2026 ($ millions)
Figure 36. Southeast Asia At-home Molecular Diagnostic Device Market Size Growth 2021-2026 ($ millions)
Figure 37. India At-home Molecular Diagnostic Device Market Size Growth 2021-2026 ($ millions)
Figure 38. Australia At-home Molecular Diagnostic Device Market Size Growth 2021-2026 ($ millions)
Figure 39. Europe At-home Molecular Diagnostic Device Market Size Market Share by Country in 2025
Figure 40. Europe At-home Molecular Diagnostic Device Market Size Market Share by Type (2021-2026)
Figure 41. Europe At-home Molecular Diagnostic Device Market Size Market Share by Application (2021-2026)
Figure 42. Germany At-home Molecular Diagnostic Device Market Size Growth 2021-2026 ($ millions)
Figure 43. France At-home Molecular Diagnostic Device Market Size Growth 2021-2026 ($ millions)
Figure 44. UK At-home Molecular Diagnostic Device Market Size Growth 2021-2026 ($ millions)
Figure 45. Italy At-home Molecular Diagnostic Device Market Size Growth 2021-2026 ($ millions)
Figure 46. Russia At-home Molecular Diagnostic Device Market Size Growth 2021-2026 ($ millions)
Figure 47. Middle East & Africa At-home Molecular Diagnostic Device Market Size Market Share by Region (2021-2026)
Figure 48. Middle East & Africa At-home Molecular Diagnostic Device Market Size Market Share by Type (2021-2026)
Figure 49. Middle East & Africa At-home Molecular Diagnostic Device Market Size Market Share by Application (2021-2026)
Figure 50. Egypt At-home Molecular Diagnostic Device Market Size Growth 2021-2026 ($ millions)
Figure 51. South Africa At-home Molecular Diagnostic Device Market Size Growth 2021-2026 ($ millions)
Figure 52. Israel At-home Molecular Diagnostic Device Market Size Growth 2021-2026 ($ millions)
Figure 53. Turkey At-home Molecular Diagnostic Device Market Size Growth 2021-2026 ($ millions)
Figure 54. GCC Countries At-home Molecular Diagnostic Device Market Size Growth 2021-2026 ($ millions)
Figure 55. Americas At-home Molecular Diagnostic Device Market Size 2027-2032 ($ millions)
Figure 56. APAC At-home Molecular Diagnostic Device Market Size 2027-2032 ($ millions)
Figure 57. Europe At-home Molecular Diagnostic Device Market Size 2027-2032 ($ millions)
Figure 58. Middle East & Africa At-home Molecular Diagnostic Device Market Size 2027-2032 ($ millions)
Figure 59. United States At-home Molecular Diagnostic Device Market Size 2027-2032 ($ millions)
Figure 60. Canada At-home Molecular Diagnostic Device Market Size 2027-2032 ($ millions)
Figure 61. Mexico At-home Molecular Diagnostic Device Market Size 2027-2032 ($ millions)
Figure 62. Brazil At-home Molecular Diagnostic Device Market Size 2027-2032 ($ millions)
Figure 63. China At-home Molecular Diagnostic Device Market Size 2027-2032 ($ millions)
Figure 64. Japan At-home Molecular Diagnostic Device Market Size 2027-2032 ($ millions)
Figure 65. Korea At-home Molecular Diagnostic Device Market Size 2027-2032 ($ millions)
Figure 66. Southeast Asia At-home Molecular Diagnostic Device Market Size 2027-2032 ($ millions)
Figure 67. India At-home Molecular Diagnostic Device Market Size 2027-2032 ($ millions)
Figure 68. Australia At-home Molecular Diagnostic Device Market Size 2027-2032 ($ millions)
Figure 69. Germany At-home Molecular Diagnostic Device Market Size 2027-2032 ($ millions)
Figure 70. France At-home Molecular Diagnostic Device Market Size 2027-2032 ($ millions)
Figure 71. UK At-home Molecular Diagnostic Device Market Size 2027-2032 ($ millions)
Figure 72. Italy At-home Molecular Diagnostic Device Market Size 2027-2032 ($ millions)
Figure 73. Russia At-home Molecular Diagnostic Device Market Size 2027-2032 ($ millions)
Figure 74. Egypt At-home Molecular Diagnostic Device Market Size 2027-2032 ($ millions)
Figure 75. South Africa At-home Molecular Diagnostic Device Market Size 2027-2032 ($ millions)
Figure 76. Israel At-home Molecular Diagnostic Device Market Size 2027-2032 ($ millions)
Figure 77. Turkey At-home Molecular Diagnostic Device Market Size 2027-2032 ($ millions)
Figure 78. Global At-home Molecular Diagnostic Device Market Size Market Share Forecast by Type (2027-2032)
Figure 79. Global At-home Molecular Diagnostic Device Market Size Market Share Forecast by Application (2027-2032)
Figure 80. GCC Countries At-home Molecular Diagnostic Device Market Size 2027-2032 ($ millions)
Figure 1. At-home Molecular Diagnostic Device Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global At-home Molecular Diagnostic Device Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. At-home Molecular Diagnostic Device Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. At-home Molecular Diagnostic Device Sales Market Share by Country/Region (2025)
Figure 8. At-home Molecular Diagnostic Device Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global At-home Molecular Diagnostic Device Market Size Market Share by Type in 2025
Figure 10. Global At-home Molecular Diagnostic Device Market Size Market Share by Test Area in 2025
Figure 11. Global At-home Molecular Diagnostic Device Market Size Market Share by Use Model in 2025
Figure 12. At-home Molecular Diagnostic Device in Home
Figure 13. Global At-home Molecular Diagnostic Device Market: Home (2021-2026) & ($ millions)
Figure 14. At-home Molecular Diagnostic Device in Retail Pharmacy
Figure 15. Global At-home Molecular Diagnostic Device Market: Retail Pharmacy (2021-2026) & ($ millions)
Figure 16. At-home Molecular Diagnostic Device in Other
Figure 17. Global At-home Molecular Diagnostic Device Market: Other (2021-2026) & ($ millions)
Figure 18. Global At-home Molecular Diagnostic Device Market Size Market Share by Application in 2025
Figure 19. Global At-home Molecular Diagnostic Device Revenue Market Share by Player in 2025
Figure 20. Global At-home Molecular Diagnostic Device Market Size Market Share by Region (2021-2026)
Figure 21. Americas At-home Molecular Diagnostic Device Market Size 2021-2026 ($ millions)
Figure 22. APAC At-home Molecular Diagnostic Device Market Size 2021-2026 ($ millions)
Figure 23. Europe At-home Molecular Diagnostic Device Market Size 2021-2026 ($ millions)
Figure 24. Middle East & Africa At-home Molecular Diagnostic Device Market Size 2021-2026 ($ millions)
Figure 25. Americas At-home Molecular Diagnostic Device Value Market Share by Country in 2025
Figure 26. United States At-home Molecular Diagnostic Device Market Size Growth 2021-2026 ($ millions)
Figure 27. Canada At-home Molecular Diagnostic Device Market Size Growth 2021-2026 ($ millions)
Figure 28. Mexico At-home Molecular Diagnostic Device Market Size Growth 2021-2026 ($ millions)
Figure 29. Brazil At-home Molecular Diagnostic Device Market Size Growth 2021-2026 ($ millions)
Figure 30. APAC At-home Molecular Diagnostic Device Market Size Market Share by Region in 2025
Figure 31. APAC At-home Molecular Diagnostic Device Market Size Market Share by Type (2021-2026)
Figure 32. APAC At-home Molecular Diagnostic Device Market Size Market Share by Application (2021-2026)
Figure 33. China At-home Molecular Diagnostic Device Market Size Growth 2021-2026 ($ millions)
Figure 34. Japan At-home Molecular Diagnostic Device Market Size Growth 2021-2026 ($ millions)
Figure 35. South Korea At-home Molecular Diagnostic Device Market Size Growth 2021-2026 ($ millions)
Figure 36. Southeast Asia At-home Molecular Diagnostic Device Market Size Growth 2021-2026 ($ millions)
Figure 37. India At-home Molecular Diagnostic Device Market Size Growth 2021-2026 ($ millions)
Figure 38. Australia At-home Molecular Diagnostic Device Market Size Growth 2021-2026 ($ millions)
Figure 39. Europe At-home Molecular Diagnostic Device Market Size Market Share by Country in 2025
Figure 40. Europe At-home Molecular Diagnostic Device Market Size Market Share by Type (2021-2026)
Figure 41. Europe At-home Molecular Diagnostic Device Market Size Market Share by Application (2021-2026)
Figure 42. Germany At-home Molecular Diagnostic Device Market Size Growth 2021-2026 ($ millions)
Figure 43. France At-home Molecular Diagnostic Device Market Size Growth 2021-2026 ($ millions)
Figure 44. UK At-home Molecular Diagnostic Device Market Size Growth 2021-2026 ($ millions)
Figure 45. Italy At-home Molecular Diagnostic Device Market Size Growth 2021-2026 ($ millions)
Figure 46. Russia At-home Molecular Diagnostic Device Market Size Growth 2021-2026 ($ millions)
Figure 47. Middle East & Africa At-home Molecular Diagnostic Device Market Size Market Share by Region (2021-2026)
Figure 48. Middle East & Africa At-home Molecular Diagnostic Device Market Size Market Share by Type (2021-2026)
Figure 49. Middle East & Africa At-home Molecular Diagnostic Device Market Size Market Share by Application (2021-2026)
Figure 50. Egypt At-home Molecular Diagnostic Device Market Size Growth 2021-2026 ($ millions)
Figure 51. South Africa At-home Molecular Diagnostic Device Market Size Growth 2021-2026 ($ millions)
Figure 52. Israel At-home Molecular Diagnostic Device Market Size Growth 2021-2026 ($ millions)
Figure 53. Turkey At-home Molecular Diagnostic Device Market Size Growth 2021-2026 ($ millions)
Figure 54. GCC Countries At-home Molecular Diagnostic Device Market Size Growth 2021-2026 ($ millions)
Figure 55. Americas At-home Molecular Diagnostic Device Market Size 2027-2032 ($ millions)
Figure 56. APAC At-home Molecular Diagnostic Device Market Size 2027-2032 ($ millions)
Figure 57. Europe At-home Molecular Diagnostic Device Market Size 2027-2032 ($ millions)
Figure 58. Middle East & Africa At-home Molecular Diagnostic Device Market Size 2027-2032 ($ millions)
Figure 59. United States At-home Molecular Diagnostic Device Market Size 2027-2032 ($ millions)
Figure 60. Canada At-home Molecular Diagnostic Device Market Size 2027-2032 ($ millions)
Figure 61. Mexico At-home Molecular Diagnostic Device Market Size 2027-2032 ($ millions)
Figure 62. Brazil At-home Molecular Diagnostic Device Market Size 2027-2032 ($ millions)
Figure 63. China At-home Molecular Diagnostic Device Market Size 2027-2032 ($ millions)
Figure 64. Japan At-home Molecular Diagnostic Device Market Size 2027-2032 ($ millions)
Figure 65. Korea At-home Molecular Diagnostic Device Market Size 2027-2032 ($ millions)
Figure 66. Southeast Asia At-home Molecular Diagnostic Device Market Size 2027-2032 ($ millions)
Figure 67. India At-home Molecular Diagnostic Device Market Size 2027-2032 ($ millions)
Figure 68. Australia At-home Molecular Diagnostic Device Market Size 2027-2032 ($ millions)
Figure 69. Germany At-home Molecular Diagnostic Device Market Size 2027-2032 ($ millions)
Figure 70. France At-home Molecular Diagnostic Device Market Size 2027-2032 ($ millions)
Figure 71. UK At-home Molecular Diagnostic Device Market Size 2027-2032 ($ millions)
Figure 72. Italy At-home Molecular Diagnostic Device Market Size 2027-2032 ($ millions)
Figure 73. Russia At-home Molecular Diagnostic Device Market Size 2027-2032 ($ millions)
Figure 74. Egypt At-home Molecular Diagnostic Device Market Size 2027-2032 ($ millions)
Figure 75. South Africa At-home Molecular Diagnostic Device Market Size 2027-2032 ($ millions)
Figure 76. Israel At-home Molecular Diagnostic Device Market Size 2027-2032 ($ millions)
Figure 77. Turkey At-home Molecular Diagnostic Device Market Size 2027-2032 ($ millions)
Figure 78. Global At-home Molecular Diagnostic Device Market Size Market Share Forecast by Type (2027-2032)
Figure 79. Global At-home Molecular Diagnostic Device Market Size Market Share Forecast by Application (2027-2032)
Figure 80. GCC Countries At-home Molecular Diagnostic Device Market Size 2027-2032 ($ millions)
